The mechanistic target of rapamycin (mTOR), a sensor of nutrient availability and growth factors, has been implicated in multiple diseases like cancer, diabetes, and neurodegenerative diseases; they are characterized by inflammation, as well as aging, referred to as “inflammaging” [43,44,45]. This evidence concerns the gene MTOR and cancer.